Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform ...

The presence of oxytocin (OXT) in seminal plasma is related to the fertility outcomes of male pigs used in artificial ...

Changes in genes have been linked to the development of different diseases for a while. However, it's not exactly clear what ...

Codexis expands reach of the ECO Synthesis Manufacturing Platform through a signed evaluation agreement with Axolabs for oligonucleotide therapeutics: Redwood City, California Mon ...

The first line of treatment for cancer is, whenever possible, to remove the cancerous tissue from the body. Though often ...

The use of nanoparticles to improve feed efficiency and poultry health has significant potential to reduce the spread of ...

Hong Kong investors can now trade in their first mRNA concept stock, following the strong trading debut for Suzhou Ribo Life ...

The first line of treatment for cancer is, whenever possible, to remove the cancerous tissue from the body. Though often ...

Bionano Genomics, Inc. (NASDAQ: BNGO) today reported certain unaudited preliminary financial results and commercial highlights for the fourth quarter and fiscal year ended December 31, 2025. "2025 was ...

New name reflects the Company’s strategic evolution focused on later-stage preclinical assets leveraging its most advanced, signature ...

Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...